Choosing the correct pain relief for extracorporeal lithotripsy.
OBJECTIVE
To determine the best choice of analgesic for patients undergoing lithotripsy, and to attempt to identify factors which might predict which patients are most likely to find the procedure painful.


METHODS
Sixty patients with stones in the pelvicalyceal system of the kidney were randomized prospectively to undergo lithotripsy with the Dornier MPL9000 lithotripter (Dormier Medical Systems, Marietta, GA, USA) after receiving either diclofenac 100 mg per rectum (n = 30) or pethidine 50 mg intravenously (n = 30) for analgesia. The patients completed a detailed questionnaire prior to treatment, and the level of pain perceived during lithotripsy was monitored using visual analogue scales (VASs). Arterial oxygen saturation (SaO2) was monitored before analgesia was given, throughout the treatment and for 30 min after cessation of treatment.


RESULTS
The VASs were available for 56 patients and the results of pulse oximetry for 51 patients. Although a higher kilovoltage was recorded in the group who received pethidine this difference was not significant. Patients who received diclofenac or pethidine alone, showed a non-significant fall of SaO2 30 minutes after the end of treatment, although the largest fall in SaO2 observed with pethidine was 10%. Patients who received diclofenac and pethidine similarly showed a non-significant fall in SaO2. Four patients received intravenous benzodiazepines in addition to pethidine, and in this group there was a dramatic fall in SaO2 which persisted more than 30 min after the end of treatment (P < 0.0027). Diclofenac provided effective analgesia for most of the patients who underwent lithotripsy. Overall 11 patients (18%) required additional analgesia. Diclofenac or pethidine alone, in the doses used in this study, did not cause a significant drop in SaO2 during ESWL. The only response found to be of value in predicting a painful experience was fear of the dentist.


CONCLUSIONS
This study shows that modern lithotripsy, in addition to being safe and effective, can be performed as an out-patient procedure using simple non-opiate analgesics. The need for stronger analgesia and/or sedation should be tailored to the needs of the individual patient, although it remains difficult to predict which patients will require such measures.
Dawson
C
C
Department of Urology, St Bartholomew's Hospital, London, UK.
Vale
J A
JA
Corry
D A
DA
Cohen
N P
NP
Gallagher
J
J
Nockler
I B
IB
Whitfield
H N
HN
D000328:Adult; D000368:Aged; D000698:Analgesia / Q000379:methods; D004008:Diclofenac / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008096:Lithotripsy / Q000009:adverse effects*; D008297:Male; D008614:Meperidine / Q000008:administration & dosage*; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010146:Pain / Q000188:drug therapy*; D010147:Pain Measurement; D011446:Prospective Studies
D004008:Diclofenac; D008614:Meperidine; D010100:Oxygen